International Journal of Cardiology: Hypertension最新文献

英文中文

Sex differences in prevalence and associated factors of prehypertension and hypertension among Bangladeshi adults 孟加拉国成年人高血压前期和高血压患病率及相关因素的性别差异

Q4 Medicine

International Journal of Cardiology: Hypertension

Pub Date : 2019-05-01 DOI: 10.1016/j.ijchy.2019.100006

Gulam Muhammed Al Kibria , Vanessa Burrowes , Allysha Choudhury , Atia Sharmeen , Krystal Swasey

Globally, complications of raised blood pressure are fundamental public health issues. There has been limited research if prevalence and risk factors vary by sex in many countries, including Bangladesh. We stratified the prevalence and associated factors of prehypertension and hypertension according to sex in Bangladesh.

This cross-sectional study analyzed the Bangladesh Demographic and Health Survey 2011 data. After estimating prevalence according to sex, multilevel logistic regression was applied to obtain associated factors.

This study analyzed data of 3876 males and 3962 females aged ≥35 years. The prevalence of hypertension was 19.4% (95% confidence interval [CI]: 18.0–21.0) among males and 31.9% (95% CI: 30.1–33.6) among females. Among both males and females, prevalence and odds of hypertension increased with age, overweight/obesity, diabetes, upper wealth status, and residence in some divisions. Education level was a significant positive correlate of hypertension for males only.

Males and females had similar prevalence of prehypertension, 27.2% (95% CI: 25.6–28.8) and 27.6% (95% CI: 26.0–29.2), respectively. Characteristics such as older age, overweight/obesity, and diabetes were associated with higher prevalence and odds of prehypertension among females; prehypertension among males was associated with advancing age, overweight/obesity, education level, wealth status, and division of residence.

In Bangladesh, almost half of the males and females could have increased risks of complications resulting from hypertension and prehypertension. Addressing the characteristics associated with higher prevalence or odds of these conditions is crucial. Several common risk factors indicate that a common prevention and control strategy could work for both sexes.

在全球范围内，高血压并发症是基本的公共卫生问题。在包括孟加拉国在内的许多国家，患病率和风险因素是否因性别而异的研究有限。我们根据性别对孟加拉国高血压前期和高血压的患病率和相关因素进行分层。这项横断面研究分析了2011年孟加拉国人口与健康调查的数据。在按性别估计患病率后，应用多水平逻辑回归获得相关因素。本研究分析了年龄≥35岁的3876名男性和3962名女性的资料。男性高血压患病率为19.4%(95%可信区间[CI]: 18.0 ~ 21.0)，女性为31.9%(95%可信区间:30.1 ~ 33.6)。在一些地区，在男性和女性中，高血压的患病率和发病率随着年龄、超重/肥胖、糖尿病、较高的财富状况和居住地而增加。仅男性受教育程度与高血压呈显著正相关。男性和女性的高血压前期患病率相似，分别为27.2% (95% CI: 25.6-28.8)和27.6% (95% CI: 26.0-29.2)。老年、超重/肥胖和糖尿病等特征与女性高血压前期患病率和几率较高相关;男性高血压前期与年龄增长、超重/肥胖、教育水平、财富状况和居住地划分有关。在孟加拉国，几乎一半的男性和女性可能会增加高血压和高血压前期引起的并发症的风险。解决与这些疾病较高患病率或几率相关的特征至关重要。几个共同的风险因素表明，一个共同的预防和控制策略可能对两性都有效。

{"title":"Sex differences in prevalence and associated factors of prehypertension and hypertension among Bangladeshi adults","authors":"Gulam Muhammed Al Kibria , Vanessa Burrowes , Allysha Choudhury , Atia Sharmeen , Krystal Swasey","doi":"10.1016/j.ijchy.2019.100006","DOIUrl":"10.1016/j.ijchy.2019.100006","url":null,"abstract":"<div><p>Globally, complications of raised blood pressure are fundamental public health issues. There has been limited research if prevalence and risk factors vary by sex in many countries, including Bangladesh. We stratified the prevalence and associated factors of prehypertension and hypertension according to sex in Bangladesh.</p><p>This cross-sectional study analyzed the Bangladesh Demographic and Health Survey 2011 data. After estimating prevalence according to sex, multilevel logistic regression was applied to obtain associated factors.</p><p>This study analyzed data of 3876 males and 3962 females aged ≥35 years. The prevalence of hypertension was 19.4% (95% confidence interval [CI]: 18.0–21.0) among males and 31.9% (95% CI: 30.1–33.6) among females. Among both males and females, prevalence and odds of hypertension increased with age, overweight/obesity, diabetes, upper wealth status, and residence in some divisions. Education level was a significant positive correlate of hypertension for males only.</p><p>Males and females had similar prevalence of prehypertension, 27.2% (95% CI: 25.6–28.8) and 27.6% (95% CI: 26.0–29.2), respectively. Characteristics such as older age, overweight/obesity, and diabetes were associated with higher prevalence and odds of prehypertension among females; prehypertension among males was associated with advancing age, overweight/obesity, education level, wealth status, and division of residence.</p><p>In Bangladesh, almost half of the males and females could have increased risks of complications resulting from hypertension and prehypertension. Addressing the characteristics associated with higher prevalence or odds of these conditions is crucial. Several common risk factors indicate that a common prevention and control strategy could work for both sexes.</p></div>","PeriodicalId":36839,"journal":{"name":"International Journal of Cardiology: Hypertension","volume":"1 ","pages":"Article 100006"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ijchy.2019.100006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38742185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 11

Hypertension among women of reproductive age: Impact of 2017 American College of Cardiology/American Heart Association high blood pressure guideline 育龄妇女高血压:2017年美国心脏病学会/美国心脏协会高血压指南的影响

Q4 Medicine

International Journal of Cardiology: Hypertension

Pub Date : 2019-05-01 DOI: 10.1016/j.ijchy.2019.100007

Han-Yang Chen, Suneet P. Chauhan

Objective

To estimate the prevalence of hypertension and antihypertensive medication recommended among U.S. reproductive-aged women according to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) guideline as compared with the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC7) guideline and to identify factors associated with newly classified hypertensive women.

Methods

We analyzed data from the National Health and Nutrition Examination Survey 2005–2014. Hypertension was defined using blood pressure measurements and/or self-reported antihypertensive medication use. Multivariable Poisson regression models with robust error variance were conducted.

Results

Among 4,575 (weighted n = 40,194,602) non-pregnant women aged 20–44 years, the prevalence of hypertension was 16.5% using the 2017 guideline, and 7.8% based on the JNC7 guideline. Following the 2017 guideline, 8.6% would be recommended for antihypertensive medication, similar to 8.5% according to JNC7 guideline. Following the 2017 guideline, women with older age (35–44 years), obesity, and diabetes were more likely, while Hispanic women were less likely, to be newly classified as hypertensive.

Conclusion

Among reproductive-aged women, compared to JNC7 guidelines, the prevalence of hypertension increased by 112% following the 2017 guideline, but the percentage of women recommended for antihypertensive medication was similar.

目的根据2017年美国心脏病学会/美国心脏协会(ACC/AHA)指南，与高血压预防、检测、评估和治疗全国联合委员会第七次报告(JNC7)指南进行比较，估计美国育龄妇女中高血压和推荐降压药的患病率，并确定新分类高血压妇女的相关因素。方法分析2005-2014年全国健康与营养调查资料。高血压是通过血压测量和/或自我报告的抗高血压药物使用来定义的。建立了具有鲁棒误差方差的多变量泊松回归模型。结果4575名(加权n = 40194602)年龄在20-44岁的非孕妇中，使用2017年指南的高血压患病率为16.5%，使用JNC7指南的高血压患病率为7.8%。根据2017年指南，抗高血压药物推荐比例为8.6%，与JNC7指南的8.5%相似。根据2017年的指南，年龄较大(35-44岁)、肥胖和糖尿病的女性更有可能被新归类为高血压，而西班牙裔女性的可能性较小。结论在育龄女性中，与JNC7指南相比，2017年指南的高血压患病率增加了112%，但推荐使用降压药物的女性比例相似。

{"title":"Hypertension among women of reproductive age: Impact of 2017 American College of Cardiology/American Heart Association high blood pressure guideline","authors":"Han-Yang Chen, Suneet P. Chauhan","doi":"10.1016/j.ijchy.2019.100007","DOIUrl":"10.1016/j.ijchy.2019.100007","url":null,"abstract":"<div><h3>Objective</h3><p>To estimate the prevalence of hypertension and antihypertensive medication recommended among U.S. reproductive-aged women according to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) guideline as compared with the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC7) guideline and to identify factors associated with newly classified hypertensive women.</p></div><div><h3>Methods</h3><p>We analyzed data from the National Health and Nutrition Examination Survey 2005–2014. Hypertension was defined using blood pressure measurements and/or self-reported antihypertensive medication use. Multivariable Poisson regression models with robust error variance were conducted.</p></div><div><h3>Results</h3><p>Among 4,575 (weighted n = 40,194,602) non-pregnant women aged 20–44 years, the prevalence of hypertension was 16.5% using the 2017 guideline, and 7.8% based on the JNC7 guideline. Following the 2017 guideline, 8.6% would be recommended for antihypertensive medication, similar to 8.5% according to JNC7 guideline. Following the 2017 guideline, women with older age (35–44 years), obesity, and diabetes were more likely, while Hispanic women were less likely, to be newly classified as hypertensive.</p></div><div><h3>Conclusion</h3><p>Among reproductive-aged women, compared to JNC7 guidelines, the prevalence of hypertension increased by 112% following the 2017 guideline, but the percentage of women recommended for antihypertensive medication was similar.</p></div>","PeriodicalId":36839,"journal":{"name":"International Journal of Cardiology: Hypertension","volume":"1 ","pages":"Article 100007"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ijchy.2019.100007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38742186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 13

首页上一页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

International Journal of Cardiology: Hypertension

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀